The ORS currently spans the District of Columbia and 24 states: Connecticut, Delaware, Georgia, Illinois, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Vermont, Virginia, West Virginia, and Wisconsin.
With support from the Office of National Drug Control Policy (ONDCP) and the Centers for Disease Control and Prevention (CDC), the ORS initiative supports innovation and research at the local, state, and regional level. The mission of the ORS is to reduce fatal and non-fatal opioid overdose rates by improved information sharing across agencies and supporting evidence-based interventions. The four strategic directions that shape the boundaries of the ORS are: law enforcement, response, treatment and recovery, and prevention.
ORS State Teams are comprised of one Drug Intelligence Officer (DIO) and one Public Health Analyst (PHA). These teams form the foundation of the ORS and operate in each ORS state. In this capacity, DIOs and PHAs are responsible for helping to increase communication, data flow, and intelligence sharing between public safety and public health sectors within and across ORS states.